Crohn's disease and SLC11A1 promoter polymorphism

Irit Chermesh*, Aviva Azriel, Michal Alter-Koltunoff, Rami Eliakim, Amir Karban, Ben Zion Levi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Crohn's disease (CD) is a chronic multifactorial inflammatory disease. The prevalence of CD in Ashkenazi Jews is higher than in Sephardic Jews. SLC11A1, also known as Nramp1, is a divalent cation antiporter essential for the elimination of intraphagosomal pathogens. SLC11A1 has seven alleles in the promoter region and previous studies have suggested an association between CD and SLC11A1. The aim of this study was to check for a possible association between SLC11A1 promoter alleles and CD in Ashkenazi Jewish patients. DNA samples from healthy Ashkenazi donors and Ashkenazi CD patients were obtained and analyzed for SLC11A1 promoter polymorphism by PCR and DNA sequencing. One hundred thirty-one samples from healthy donors and 131 samples from CD patients were analyzed. Four alleles were identified: ∼70% of the samples carried allele 3; ∼30%, allele 2; ∼1%, allele 1; and <1%, allele 5. There was no difference in allele frequencies between healthy donors and CD patients. No correlation was found between mutations in NOD2/CARD15 and the phenotype of CD. We conclude that the difference in SLC11A1 promoter polymorphism plays no role in CD in Ashkenazi Jews.

Original languageEnglish
Pages (from-to)1632-1635
Number of pages4
JournalDigestive Diseases and Sciences
Issue number7
StatePublished - Jul 2007
Externally publishedYes


  • Alleles
  • Crohn's disease
  • Genetics
  • Inflammatory bowel disease
  • Promoter polymorphism
  • SLC11A1
  • Ulcerative colitis


Dive into the research topics of 'Crohn's disease and SLC11A1 promoter polymorphism'. Together they form a unique fingerprint.

Cite this